Oral poly(ADP)-ribose polymerase (PARP) inhibitors have been shown to have great promise in the treatment of cancer inBRCA mutation carriers. This case provides evidence that these agents are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results